Total and single doses influence the effectiveness of radiotherapy in palliative treatment of plasmacytoma

Strahlentherapie und Onkologie

Volumn 184, Issue 9, 2008, Pages 465-472

  Stölting, Thomas ^a   Knauerhase, Hellen ^a   Klautke, Gunther ^a   Kundt, Günther ^a   Fietkau, Rainer ^a,b,c  

^a UNIVERSITY OF ROSTOCK   (Germany)

^b UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^c UNIVERSITY HOSPITAL ERLANGEN   (Germany)

Author keywords

Multiple myeloma; Pain relief; Plasmacytoma; Radiotherapy; Recalcification

Indexed keywords

ANALGESIC AGENT; BISPHOSPHONIC ACID DERIVATIVE; DEXAMETHASONE; IDARUBICIN; MELPHALAN; PREDNISOLONE;

ADOLESCENT; ADULT; AGED; ANALGESIA; ARTICLE; CALCIFICATION; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; FEMALE; FRACTURE; HUMAN; MAJOR CLINICAL STUDY; MALE; PLASMACYTOMA; PROGNOSIS; RADIATION DOSE; RETROSPECTIVE STUDY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CALCINOSIS; COMBINED MODALITY THERAPY; DOSE FRACTIONATION; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTIPLE MYELOMA; MULTIVARIATE ANALYSIS; NEOPLASM STAGING; PAIN MEASUREMENT; PALLIATIVE CARE; PLASMACYTOMA; PROGNOSIS; RADIOTHERAPY DOSAGE; RETROSPECTIVE STUDIES; SURVIVAL RATE; TREATMENT OUTCOME; YOUNG ADULT;

EID: 56549103661     PISSN: 01797158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00066-008-1808-4     Document Type: Article

References (31)

1. Adamietz IA, Schober C, Schulte RW, et al. Palliative radiotherapy in plasma cell myeloma. Radiother Onkol 1991;20:111-6.
2. Bataille R, Harousseau J-L. Multiple myeloma. N Engl J Med 1997;336:1657-64.
3. Bosch A, Frias Z. Radiotherapy in the treatment of the multiple myeloma. Int J Radiat Oncol Biol Phys 1988;15:1363-9.
4. Dimopoulos MA, Goldstein J, Fuller, et al. Curability of solitary bone plasmacytoma. J Clin Oncol 1992;10:587-90.
5. Eble MJ, Eckert W, Wannenmacher M. Stellenwert der lokalen Strahlentherapie in der Behandlung ossärer Metastasen, pathologischer Frakturen und Myelonkompressionen. Radiologe 1995;35:47-54.
6. Eble MJ, Wannenmacher M. Topical radiotherapy in the treatment of skeletal metastases. Orthopäde 1998;27:245-9.
7. Farhangi M, Ossermann E. The treatment of multiple myeloma. Semin Hematol 1973;10:149-61.
8. Frassica DA, Frassica FJ, Schray MF, et al. Solitary plasmacytoma of bone: Mayo Clinic experience. Int J Radiat Oncol Biol Phys 1989;6:43-8.
9. Hartsell WF, Scott CB, Bruner WD, et al. Randomized trial of short- versus long course radiotherapy for palliation of painful bone metastases. J Natl Cancer Inst 1995;97:798-804.
10. Hu K, Yahalom J. Radiotherapy in the management of plasma cell tumors. Oncology (Huntingt) 2000;14:101-8, 111, discussion 111-2, 115.
11. Klautke G, Fietkau R. Significance of radiation therapy for adenocarcinomas of the esophagus, gastroesophageal junction and gastric cancer with special reference to the MAGIC trial. Strahlenther Onkol 2007;183:163-9.
12. Köst S. Indikationen und Ergebnisse der Strahlentherapie beim Plasmozytom. Radiobiol Radiother 1990;31:231-7.
13. Koswig S, Budach V. Remineralisation und Schmerzlinderung von Knochenmetastasen nach unterschiedlich fraktionierter Strahlentherapie (10mal 3 Gy vs. 1mal 8 Gy). Strahlenther Onkol 1999;175:500-8.
14. Kyle RA, Gertz MA, Witzig TE, et al. Review of 1027 patients with newly diagnosed multiple myeloma. Mayo Clin Proc 2003;78:21-33.
15. Leigh BR, Kurtts TA, Curtis FM, et al. Radiation therapy for the palliation of multiple myeloma. Int J Radiat Oncol Biol Phys 1993;25:801-4.
16. Liebros RH, Ha CS, Cox JD. Solitary bone plasmacytoma: outcome and prognostic factors following radiotherapy. Int J Radiat Oncol Biol Phys 1998;441:1063-7.
17. Mayr NA, Wen BC, Hussey DH, et al. The role of radiation therapy in the treatment of solitary plasmacytomas. Radiother Oncol 1990;17:293-303.
18. Mendenhall CM, Thar TL, Million RR. Solitary plasmozytoma of bone and soft tissue. Int J Radiat Oncol Biol Phys 1980;6:1497-501.
19. Meran JG, Zojer N, Ludwig H. Klinik, Diagnose und Prognose des multiplen Myeloms. Onkologe 1999;5:297-306.
20. Mill WB, Griffith R. The role of radiation therapy in the management of plasmacell tumors. Cancer 1980;45:647-52.
21. Mills BW, Wassermann TH. Multiple myeloma in plasmozytomas. In: Perez C, Brady LB, eds. Principles and practice of radiation oncology. Philadelphia: Lippincott, 1987:1086-100.
22. Minowa Y, Sasai K, Ishigaki T, et al. Palliative radiation therapy for multiple myeloma. Nippon Igaku Hoshasen Gakkai Zasshi 1996;56:1056-60.
23. Mose S, Pfitzner D, Rahn A, et al. Wertigkeit der Radiologie in der Behandlung des multiplen Myeloms. Strahlenther Onkol 2000;176:506-12.
24. Norin T. Roentgen treatment of myleoma with special consideration to the dosage. Acta Radiol 1957;47:46-54.
25. Olschewski T, Seegenschmiedt H. Radiotherapy for bony manifestations of Langerhans cell histiocytosis. Review and proposal for an international registry. Strahlenther Onkol 2006;182:72-9.
26. Rades D, Dahm-Daphi J, Rudat V, et al. Is short-course radiotherapy with high doses per fraction the appropriate regimen for metastatic spinal cord compression in colorectal cancer patients? Strahlenther Onkol 2006;182:708-12.
27. Renner H. Strahlentherapeutische Aspekte des multiplen Myeloms. Strahlentherapie 1973;146:15-23.
28. Rieden K, Kober B, Mende U, et al. Strahlentherapie pathologischer Frakturen und frakturgefährdeter Skelettläsionen. Strahlenther Onkol 1986;162:742-9.
29. Sauer N, Leising D, Wild B, et al. Pain and quality of life following palliative radiotherapy of bone metastases. Strahlenther Onkol 2006;182:550-6.
30. Semrau S, Bier A, Thierbach U, et al. 6-year experience of concurrent radiochemotherapy with vinorelbine plus a platinum compound in multimorbid or aged patients with inoperable non-small cell lung cancer. Strahlenther Onkol 2007;183:30-5.
31. Semrau S, Gerber B, Reimer T, et al. Concurrent radiotherapy and taxane chemotherapy in patients with locoregional recurrence of breast cancer. A retrospective analysis. Strahlenther Onkol 2006;182:596-603.